Patents Assigned to NANOCAV, LLC
  • Patent number: 11639510
    Abstract: Devices and methods are presented for delivery of various macrostructures into cells, such as depleted cells as well as methods of generating engineered cells using said devices and methods. Cells are placed on a porous membrane. A force is applied by a configurable actuator to a deformable fluid reservoir that generates an applied pressure to macrostructures in a solution, causing the macrostructures to pass through the porous membrane and triggering uptake of at least some of the macrostructures into the cells to form transfected cells. Said devices and methods may be used in a process to replace defective endogenous mtDNA with corrected mtDNA to generate cellular-based therapeutics for administration to a patient. The customizable actuator may be configured with parameters to optimize efficiency for a given cell type and material to be transfected. Machine learning techniques also may be utilized to optimize transfection parameters.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: May 2, 2023
    Assignee: NANOCAV, LLC
    Inventors: Ting-Hsiang Sherry Wu, Artin Mehrabi, Jon Thomas Van Lew
  • Patent number: 11554173
    Abstract: Methods are provided for transfecting cells with large cargo using a poly(beta-amino ester) (PBAE) molecule, and achieving high efficiency and viability. A method is provided of transfecting cells with a cargo, by forming a complex of the cargo with a (PBAE) molecule, mixing the complex with a first buffer and contacting the complex with the cells, wherein the cargo has a dimension of at least 0.1 ?m. The PBAE molecule may be formed by reacting an amine with a di(acrylate ester). In some aspects, the PBAE molecule is poly(1,4-butanediol diacrylate-co-4-amino-1-butanol). In some aspects, the PBAE molecule is capped with 1-(3-aminopropyl)-4-methylpiperazine.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 17, 2023
    Assignee: NANOCAV, LLC
    Inventors: Ting-Hsiang Sherry Wu, Wade Nichols Richardson
  • Patent number: 11549089
    Abstract: A transfection device suitable for delivery of various macrostructures (e.g., mitochondria, bacteria, liposomes) is described and uses mechanical force to thereby induce active endocytosis in a target cell. Contemplated devices are able to achieve high throughput of transfected cells that remain viable and are capable of producing colonies.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: January 10, 2023
    Assignee: NANOCAV, LLC
    Inventor: Ting Wu
  • Patent number: 11426724
    Abstract: Systems and methods for using microfluidic devices to concentrate cells, to perform buffer changes, to sort cells based on size, and/or to isolate particular types of cells in a rapid manner, are presented. Cells flow into a matrix of posts, wherein the posts are distributed along diagonal lines in the chamber. The cells are deflected in a lateral manner, towards a side of a chamber and are collected upon exiting the chamber.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: August 30, 2022
    Assignee: NANOCAV, LLC
    Inventor: Yu-Chun Kung
  • Patent number: 11377652
    Abstract: Systems and methods are provided for transfecting cells, such as mammalian cells and nonmammalian cells, using an electroporation apparatus having an electroporation chamber including an upper micromesh electrode, a lower micromesh electrode and a path defined in the electroporation chamber. The electroporation apparatus includes a first input allowing passage of cells into the electroporation chamber and a first output allowing passage of electroporated cells from the electroporation chamber. The first input and the first output are separated by an offset distance.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: July 5, 2022
    Assignee: NANOCAV, LLC
    Inventor: Chih-Wei Chang
  • Patent number: 11278606
    Abstract: Methods for preparing antigen-loaded dendritic cells (DCs) for treatment of cancer in a subject are provided, using an electroporation apparatus having an electroporation chamber including an upper electrode, a lower electrode and a path defined in the electroporation chamber. The electroporation apparatus includes a first input allowing passage of DCs into the electroporation chamber and a first output allowing passage of antigen-loaded DCs from the electroporation chamber. The first input and the first output are separated by an offset distance. Methods of treating cancer by administering antigen-loaded DCs are also provided.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: March 22, 2022
    Assignees: NANT HOLDINGSIP, LLC, NANOCAV, LLC
    Inventors: Patrick Soon-Shiong, Chihwei Chang
  • Patent number: 11046976
    Abstract: Systems and methods for transfection devices are contemplated for delivery of various complex macrostructures. Preferred systems and methods are suitable for mRNA reprogramming and genome editing and use mechanical force to induce uptake of the macrostructures in a target cell. Contemplated devices are able to achieve high throughput of transfected cells in remarkably short time that remain viable and are capable of producing colonies.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: June 29, 2021
    Assignee: NanoCav, LLC
    Inventor: Ting Wu
  • Patent number: 10760040
    Abstract: A transfection device suitable for delivery of various macrostructures (e.g., mitochondria, bacteria, liposomes) is described and uses mechanical force to thereby induce active endocytosis in a target cell. Contemplated devices are able to achieve high throughput of transfected cells that remain viable and are capable of producing colonies.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: September 1, 2020
    Assignee: NANOCAV, LLC
    Inventor: Ting Wu
  • Patent number: 10252269
    Abstract: Methods and devices are provided for focusing and/or sorting activated T cells. The device comprises a microfluidic channel comprising a plurality of electrodes arranged to provide dielectrophoretic (DEP) forces that are perpendicular to forces from hydrodynamic flows along the channel. The device may be configured to apply voltages to a plurality of electrodes in a first upper region of the microfluidic channel to focus the cells into a single flow, and to apply different voltages to a plurality of electrodes in a second downstream region of the microfluidic channel to sort cells based on size. The output of the microfluidic channel may diverge into multiple channels, wherein cells of various sorted sizes are directed into the appropriate output channel.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: April 9, 2019
    Assignees: NANTBIO, INC., NANOCAV, LLC
    Inventors: Yu-Chun Kung, Ting-Hsiang Wu, Peter Sieling, Kayvan Niazi
  • Patent number: D1016324
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: February 27, 2024
    Assignee: NanoCav, LLC
    Inventors: Chihwei Chang, Wade Richardson, Artin Mehrabi